Skip to main content
Skip to footer

Reinstating the Pharma Supply Chain Post COVID-19 Pandemic Disruptions

Mithugopal Mandal

Senior Management Consultant, Life Sciences Advisory Services, TCS

The crisis has triggered the need for approaches that companies can take to circumvent challenges and get their production back on track

Supply chain is the backbone of pharma manufacturing. Global disruptions from COVID-19 pandemic have severely impacted the supply chains. Unless the organizations plan effectively, there is a chance it may take longer to recover than expected. This whitepaper addresses the key areas the organizations need to focus on and take the quick action.

 

About the Author

Mithugopal Mandal
Mithugopal is a Senior Management Consultant in TCS’ Life Science Advisory Practice.